These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 11340171)
1. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Johansen LM; Iwama A; Lodie TA; Sasaki K; Felsher DW; Golub TR; Tenen DG Mol Cell Biol; 2001 Jun; 21(11):3789-806. PubMed ID: 11340171 [TBL] [Abstract][Full Text] [Related]
2. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells. Ishida S; Shudo K; Takada S; Koike K Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791 [TBL] [Abstract][Full Text] [Related]
3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253 [TBL] [Abstract][Full Text] [Related]
4. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. Numata A; Shimoda K; Kamezaki K; Haro T; Kakumitsu H; Shide K; Kato K; Miyamoto T; Yamashita Y; Oshima Y; Nakajima H; Iwama A; Aoki K; Takase K; Gondo H; Mano H; Harada M J Biol Chem; 2005 Apr; 280(13):12621-9. PubMed ID: 15664994 [TBL] [Abstract][Full Text] [Related]
5. Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Zada AA; Pulikkan JA; Bararia D; Geletu M; Trivedi AK; Balkhi MY; Hiddemann WD; Tenen DG; Behre HM; Behre G Leukemia; 2006 Dec; 20(12):2137-46. PubMed ID: 17082780 [TBL] [Abstract][Full Text] [Related]
6. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding. Cleaves R; Wang QF; Friedman AD Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Rangatia J; Vangala RK; Treiber N; Zhang P; Radomska H; Tenen DG; Hiddemann W; Behre G Mol Cell Biol; 2002 Dec; 22(24):8681-94. PubMed ID: 12446786 [TBL] [Abstract][Full Text] [Related]
9. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719 [TBL] [Abstract][Full Text] [Related]
10. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E; Jensen MR; Thorgeirsson SS Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068 [TBL] [Abstract][Full Text] [Related]
11. Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells. Hara E; Okamoto S; Nakada S; Taya Y; Sekiya S; Oda K Oncogene; 1993 Apr; 8(4):1023-32. PubMed ID: 8384353 [TBL] [Abstract][Full Text] [Related]
12. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500 [TBL] [Abstract][Full Text] [Related]
13. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389 [TBL] [Abstract][Full Text] [Related]
14. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth. Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988 [TBL] [Abstract][Full Text] [Related]
15. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation. Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402 [TBL] [Abstract][Full Text] [Related]
17. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Slomiany BA; D'Arigo KL; Kelly MM; Kurtz DT Mol Cell Biol; 2000 Aug; 20(16):5986-97. PubMed ID: 10913181 [TBL] [Abstract][Full Text] [Related]
18. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245 [TBL] [Abstract][Full Text] [Related]
19. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Porse BT; Pedersen TA ; Xu X; Lindberg B; Wewer UM; Friis-Hansen L; Nerlov C Cell; 2001 Oct; 107(2):247-58. PubMed ID: 11672531 [TBL] [Abstract][Full Text] [Related]
20. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells. Cammenga J; Mulloy JC; Berguido FJ; MacGrogan D; Viale A; Nimer SD Blood; 2003 Mar; 101(6):2206-14. PubMed ID: 12406909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]